Form 8-K - Current report:
SEC Accession No. 0001140361-25-046134
Filing Date
2025-12-19
Accepted
2025-12-19 09:24:53
Documents
28
Period of Report
2025-12-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20061157_8k.htm   iXBRL 8-K 63634
2 EXHIBIT 2.1 ef20061157_ex2-1.htm EX-2.1 647363
3 EXHIBIT 3.1 ef20061157_ex3-1.htm EX-3.1 3257
4 EXHIBIT 99.1 ef20061157_ex99-1.htm EX-99.1 53175
5 EXHIBIT 99.2 ef20061157_ex99-2.htm EX-99.2 17583
6 EXHIBIT 99.3 ef20061157_ex99-3.htm EX-99.3 13961
7 EXHIBIT 99.4 ef20061157_ex99-4.htm EX-99.4 17685
8 EXHIBIT 99.5 ef20061157_ex99-5.htm EX-99.5 67688
9 EXHIBIT 99.6 ef20061157_ex99-6.htm EX-99.6 16537
10 EXHIBIT 99.7 ef20061157_ex99-7.htm EX-99.7 15891
11 EXHIBIT 99.8 ef20061157_ex99-8.htm EX-99.8 18470
15 ef20061157_ex99-7slide1.jpg GRAPHIC 221098
16 ef20061157_ex99-7slide2.jpg GRAPHIC 365257
17 image0.jpg GRAPHIC 8820
18 image00001.jpg GRAPHIC 48891
19 image00002.jpg GRAPHIC 3305
20 image00004.jpg GRAPHIC 4673
  Complete submission text file 0001140361-25-046134.txt   2209683

Data Files

Seq Description Document Type Size
12 XBRL TAXONOMY EXTENSION SCHEMA fold-20251219.xsd EX-101.SCH 3869
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE fold-20251219_lab.xml EX-101.LAB 22692
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fold-20251219_pre.xml EX-101.PRE 16555
30 EXTRACTED XBRL INSTANCE DOCUMENT ef20061157_8k_htm.xml XML 4224
Mailing Address 47 HULFISH STREET PRINCETON NJ 08542
Business Address 47 HULFISH STREET PRINCETON NJ 08542 (609) 662-2000
AMICUS THERAPEUTICS, INC. (Filer) CIK: 0001178879 (see all company filings)

EIN.: 200422823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33497 | Film No.: 251585521
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)